etoposide has been researched along with meglumine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Horton, JK; Reuss, L; Vanoye, CG | 1 |
| Boughamoura, L; Bouguila, J; Chabchoub, I; Essoussi, AS; Mlika, A; Moncef, Y; Saghrouni, F | 1 |
3 other study(ies) available for etoposide and meglumine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Swelling-activated chloride currents in a drug-sensitive cell line and a P glycoprotein-expressing derivative are underlied by channels with the same pharmacological properties.
Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Cell Size; Chloride Channels; Colchicine; Cytochalasin D; Cytoskeleton; Electrophysiology; Etoposide; Humans; Hypertonic Solutions; Hypotonic Solutions; Meglumine; Nitrobenzenes; Tumor Cells, Cultured; Verapamil; Vinblastine | 1998 |
[Treatment of severe hemophagocytic syndrome associated with visceral leishmaniasis].
Topics: Animals; Antineoplastic Agents, Phytogenic; Antiprotozoal Agents; Drug Therapy, Combination; Etoposide; Fatal Outcome; Glucocorticoids; Humans; Immunoglobulins; Infant; Leishmania; Leishmaniasis, Visceral; Lymphohistiocytosis, Hemophagocytic; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome | 2010 |